2 terminated, 1 completed, 1 not yet recruiting, 1 recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Not applicable | 1 | Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow ACTH-Secreting Pituitary Adenoma: new trials by email Literature Review of ACTH-Secreting Pituitary Adenoma trials Research Report on ACTH-Secreting Pituitary Adenoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Osilodrostat Therapy and 11C-methionine PET to Improve Corticotroph Adenoma Detection 11C-Methionine PET/CT - Cushing's Disease, Hypercortisolism | Not yet recruiting | Imperial College London | 15 | 2024-12-03 | 2024-12-03 | |
| Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors. Data-only evaluation of [18F]FET PET, pituitary MRI, and biomarkers - Cushing Disease, ACTH-producing Pituitary Tumour | Recruiting | Hospices Civils de Lyon | 20 | 2023-11-23 | 2026-03-11 | |
| Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools Educational Intervention - Pituitary Neoplasms, Prolactinoma | Not applicable | Unknown | Unity Health Toronto | 60 | 2014-02-01 | 2015-07-31 |
| Pasireotide Therapy in Patients With Nelson's Syndrome Pasireotide - Nelson Syndrome | Phase 2 | Terminated | Sheffield Teaching Hospitals NHS Foundation Trust | 8 | 2011-03-01 | 2016-11-02 |
| Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin pasireotide LAR - Pancreatic Neoplasm, Pituitary Neoplasm | Phase 2 | Terminated | Novartis Pharmaceuticals | 118 | 2009-09-01 | 2016-07-26 |
| Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor Cabergoline - Cushing's Disease, Corticotroph Adenoma | Phase 3 | Completed | Seth Gordhandas Sunderdas Medical College | 2007-11-01 | 2009-04-29 |
Pituitary ACTH Hypersecretion (3) · Pituitary Neoplasms (3) · Nelson Syndrome (2) · ACTH Syndrome, Ectopic (1) · Cushing Syndrome (1) · Gigantism (1) · Growth Hormone-Secreting Pituitary Adenoma (1) · Neuroectodermal Tumors, Primitive (1) · Pancreatic Neoplasms (1) · Pituitary Diseases (1) · Prolactinoma (1)
Brain Diseases (6) · Central Nervous System Diseases (6) · Endocrine Gland Neoplasms (6) · Endocrine System Diseases (6) · Hypothalamic Diseases (6) · Neoplasms (6) · Neoplasms by Site (6) · Nervous System Diseases (6) · Neoplasms by Histologic Type (5) · Neoplasms, Glandular and Epithelial (5) · Pituitary Diseases (5) · Adenoma (4) · Hyperpituitarism (4) · Brain Neoplasms (3) · Central Nervous System Neoplasms (3)
pasireotide (2) · Biomarkers (1) · Cabergoline (1) · Early Intervention, Educational (1)
Hospices Civils de Lyon (1) · Imperial College London (1) · Novartis Pharmaceuticals (1) · Seth Gordhandas Sunderdas Medical College (1) · Sheffield Teaching Hospitals NHS Foundation Trust (1) · Unity Health Toronto (1)
Canada (2) · France (2) · Argentina (1) · Australia (1) · Brazil (1) · Germany (1) · India (1) · Italy (1) · Mexico (1) · Russia (1) · Spain (1) · Thailand (1) · United Kingdom (1) · United States (1)
John Newell-Price (1) · Michael Cusimano, MD, PhD (1) · Nalini S Shah, DM (1)
2008 (1), 2009 (1)